Logo image
Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes
Journal article   Peer reviewed

Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes

Hyo-Bum Kwak, Anna Thalacker-Mercer, Ethan J Anderson, Chien-Te Lin, Daniel A Kane, Nam-Sihk Lee, Ronald N Cortright, Marcas M Bamman and P. Darrell Neufer
Free radical biology & medicine, Vol.52(1), pp.198-207
01/01/2012
DOI: 10.1016/j.freeradbiomed.2011.10.449
PMCID: PMC3313473
PMID: 22080086
url
https://www.ncbi.nlm.nih.gov/pmc/articles/3313473View
Open Access

Abstract

Statins, the widely prescribed cholesterol-lowering drugs for the treatment of cardiovascular disease, cause adverse skeletal muscle side effects ranging from fatigue to fatal rhabdomyolysis. The purpose of this study was to determine the effects of simvastatin on mitochondrial respiration, oxidative stress, and cell death in differentiated primary human skeletal muscle cells (i.e., myotubes). Simvastatin induced a dose-dependent decrease in viability of proliferating and differentiating primary human muscle precursor cells, and a similar dose-dependent effect was noted in differentiated myoblasts and myotubes. Additionally, there were decreases in myotube number and size following 48h of simvastatin treatment (5μM). In permeabilized myotubes, maximal ADP-stimulated oxygen consumption, supported by palmitoylcarnitine+malate (PCM, complex I and II substrates) and glutamate+malate (GM, complex I substrates), was 32–37% lower (P<0.05) in simvastatin-treated (5μM) vs control myotubes, providing evidence of impaired respiration at complex I. Mitochondrial superoxide and hydrogen peroxide generation were significantly greater in the simvastatin-treated human skeletal myotube cultures compared to control. In addition, simvastatin markedly increased protein levels of Bax (proapoptotic, +53%) and Bcl-2 (antiapoptotic, +100%, P<0.05), mitochondrial PTP opening (+44%, P<0.05), and TUNEL-positive nuclei in human skeletal myotubes, demonstrating up-regulation of mitochondrial-mediated myonuclear apoptotic mechanisms. These data demonstrate that simvastatin induces myotube atrophy and cell loss associated with impaired ADP-stimulated maximal mitochondrial respiratory capacity, mitochondrial oxidative stress, and apoptosis in primary human skeletal myotubes, suggesting that mitochondrial dysfunction may underlie human statin-induced myopathy. ► Statins can induce muscle weakness/myopathy. ► In culture, simvastatin induced dose dependent atrophy of human myotubes. ► Statin exposure decreased mitochondrial respiratory function and increased ROS production. ► Activation of apoptosis also evident. ► Findings suggest mitochondrial dysfunction underlies statin-induced myopathy.
Oxidative stress Mitochondria Hydrogen peroxide Simvastatin Mitochondrial respiration Superoxide Human skeletal muscle Apoptosis

Details

Metrics

Logo image